{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,9,12]],"date-time":"2025-09-12T19:30:51Z","timestamp":1757705451914},"reference-count":12,"publisher":"Springer Science and Business Media LLC","issue":"2","license":[{"start":{"date-parts":[[1992,3,1]],"date-time":"1992-03-01T00:00:00Z","timestamp":699408000000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Eur J Clin Pharmacol"],"published-print":{"date-parts":[[1992,3]]},"DOI":"10.1007\/bf01740668","type":"journal-article","created":{"date-parts":[[2005,6,17]],"date-time":"2005-06-17T20:32:03Z","timestamp":1119040323000},"page":"185-187","source":"Crossref","is-referenced-by-count":4,"title":["A low molecular weight heparin decreases plasma aldosterone in patients with primary hyperaldosteronism"],"prefix":"10.1007","volume":"43","author":[{"given":"N.","family":"Cailleux","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"N.","family":"Moore","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"H.","family":"Levesque","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"H.","family":"Courtois","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"M.","family":"Godin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"key":"BF01740668_CR1","doi-asserted-by":"crossref","first-page":"1437","DOI":"10.1136\/bmj.300.6737.1437","volume":"300","author":"H Levesque","year":"1990","unstructured":"Levesque H, Verdier S, Cailleux N et al. (1990) Low molecular weight heparins and hypoaldosteronism. Br Med J 300: 1437\u20131438","journal-title":"Br Med J"},{"key":"BF01740668_CR2","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1016\/0039-128X(66)90133-4","volume":"7","author":"HC Ford","year":"1966","unstructured":"Ford HC, Bailey RE (1966) The effect of heparin on aldosterone secretion and metabolism in primary hyperaldosteronism. Steroids 7: 30\u201340","journal-title":"Steroids"},{"key":"BF01740668_CR3","doi-asserted-by":"crossref","first-page":"527","DOI":"10.1210\/jcem-26-5-527","volume":"26","author":"JW Conn","year":"1966","unstructured":"Conn JW, Rovner DR, Cohen EL, Anderson JE, Jr (1966) Inhibition by heparinoid of aldosterone biosynthesis in man. J Clin Endocr 26: 527\u2013532","journal-title":"J Clin Endocr"},{"key":"BF01740668_CR4","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1159\/000167106","volume":"6","author":"RA Sherman","year":"1986","unstructured":"Sherman RA, Ruddy MC (1986) Suppression of aldosterone by low-dose heparin. Am J Nephrol 6: 165\u2013168","journal-title":"Am J Nephrol"},{"key":"BF01740668_CR5","doi-asserted-by":"crossref","first-page":"108","DOI":"10.1210\/jcem-56-1-108","volume":"56","author":"R O'Kelly","year":"1983","unstructured":"O'Kelly R, Magee F, McKenna TJ (1983) Routine heparin therapy inhibits adrenal aldosterone production. J Clin Endocr Metab 56: 108\u2013112","journal-title":"J Clin Endocr Metab"},{"key":"BF01740668_CR6","doi-asserted-by":"crossref","first-page":"367","DOI":"10.1530\/acta.0.1190367","volume":"119","author":"S Azukizawa","year":"1988","unstructured":"Azukizawa S, Iwasaki I, Kigoshi T, Uchida K, Morimoto S (1988) Effects of heparin treatment in vivo and in vitro on adrenal angiotensin II induced aldosterone production in rats. Acta Endocrinol (Copenh) 119: 367\u2013372","journal-title":"Acta Endocrinol (Copenh)"},{"key":"BF01740668_CR7","doi-asserted-by":"crossref","first-page":"222","DOI":"10.1530\/acta.0.1110222","volume":"111","author":"K Uchida","year":"1986","unstructured":"Uchida K, Azukizawa S, Imaizumi N, Kigoshi T, Yamamoto I, Hosojima H, Morimoto S (1986) Effect of angiotensin II on aldosterone and its precursor steroid production in adrenal zona glomerulosa cells from heparin-treated rats. Acta Endocrinol (Copenh) 111: 222\u2013227","journal-title":"Acta Endocrinol (Copenh)"},{"key":"BF01740668_CR8","doi-asserted-by":"crossref","first-page":"455","DOI":"10.1016\/0022-4731(86)90261-X","volume":"25","author":"S Azukizawa","year":"1986","unstructured":"Azukizawa S, Uchida K, Imaizumi N, Hosojima H, Morimoto S (1986) Direct effects of heparin on basal and stimulated aldosterone production in rat adrenal glomerulosa cells. J Steroid Biochem 25: 455\u2013457","journal-title":"J Steroid Biochem"},{"key":"BF01740668_CR9","doi-asserted-by":"crossref","first-page":"244","DOI":"10.1177\/106002809002400305","volume":"24","author":"L Aull","year":"1990","unstructured":"Aull L, Chao H, Coy K (1990) Heparin-induced hyperkalemia. DICP 24: 244\u2013246","journal-title":"DICP"},{"key":"BF01740668_CR10","doi-asserted-by":"crossref","first-page":"1070","DOI":"10.1001\/archinte.1985.00360060134021","volume":"145","author":"TE Edes","year":"1985","unstructured":"Edes TE, Sunderrajan EV (1985) Heparin-induced hyperkalemia. Arch Intern Med 145: 1070\u20131072","journal-title":"Arch Intern Med"},{"key":"BF01740668_CR11","doi-asserted-by":"crossref","first-page":"415","DOI":"10.1007\/BF00558513","volume":"37","author":"M Monreal","year":"1989","unstructured":"Monreal M, Lafoz E, Salvador R, Roncales J, Navarro A (1989): Adverse effects of three different forms of heparin therapy: thrombocytopenia, increased transaminases, and hyperkalemia. Eur J Clin Pharmacol 37: 415\u2013418","journal-title":"Eur J Clin Pharmacol"},{"key":"BF01740668_CR12","doi-asserted-by":"crossref","first-page":"357","DOI":"10.1097\/00005792-198511000-00001","volume":"64","author":"HP Pone","year":"1985","unstructured":"Pone HP, Jennings AE, Madias NE, Harrington JT (1985) Druginduced hyperkalemia. Medicine 64: 357\u2013370","journal-title":"Medicine"}],"container-title":["European Journal of Clinical Pharmacology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/BF01740668.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/BF01740668\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/BF01740668","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,5,9]],"date-time":"2019-05-09T06:58:09Z","timestamp":1557385089000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/BF01740668"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[1992,3]]},"references-count":12,"journal-issue":{"issue":"2","published-print":{"date-parts":[[1992,3]]}},"alternative-id":["BF01740668"],"URL":"https:\/\/doi.org\/10.1007\/bf01740668","relation":{},"ISSN":["0031-6970","1432-1041"],"issn-type":[{"value":"0031-6970","type":"print"},{"value":"1432-1041","type":"electronic"}],"subject":[],"published":{"date-parts":[[1992,3]]}}}